Equity Research Associate, Neuroscience
Leerink Partners
About this role
An Equity Research Associate in Neuroscience supports senior research staff at an investment bank by contributing expertise in neuroscience and biopharma to inform equity research. The role is based in New York and sits within the firm’s equity research team focused on healthcare clients and institutional audiences. Ideal candidates have advanced scientific training and a strong interest in financial markets and securities analysis.
Skills
Qualifications
About Leerink Partners
leerink.comLeerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies.
Recent company news
Leerink Partners Adds Timothy Michel to Trading and Execution Team
Nov 18, 2025
Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
3 days ago
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
21 hours ago
He was on the brink amid SVB’s collapse. Now, Jeff Leerink’s firm leads the pack in health care deals.
2 weeks ago
PureTech to Present at the Leerink Partners Global Healthcare Conference
2 weeks ago
About Leerink Partners
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Leerink Partners.
Salary
$110k – $150k
per year
More jobs at Leerink Partners
Similar Jobs
Equity Research Associate - Biotechnology
TD Bank Group
Equity Research Associate - Payments, Processors & IT Services
TD Bank Group
Equity Research Associate, FinTech
KeyBank
Equity Research Associate - Communication Services
KeyBank
Equity Research Associate - Consumer Retail
TD Bank Group
Equity Research Associate - Consumer Hardlines, TD Securities
TD Bank Group